Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg

Clinical trial NCT06233045 · UNKNOWN

Trial details

NCT number: NCT06233045
Sponsor: Bio-innova Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-07-23
Primary completion: 2024-08-25
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.